ADRENALIN (EPINEPHRINE) is a Intramuscular; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Epinephrine.
| Product ID | 51662-1290_7663c49d-1b1e-755d-e053-2991aa0a4ee3 |
| NDC | 51662-1290 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ADRENALIN (EPINEPHRINE) |
| Generic Name | Adrenalin (epinephrine) |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR; SUBCUTANEOUS |
| Marketing Start Date | 2018-09-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA204200 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | EPINEPHRINE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2018-09-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA204200 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-04-30 |
| Marketing Category | NDA |
| Application Number | NDA204200 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-09-21 |
| Inactivation Date | 2020-01-31 |
| Reactivation Date | 2020-02-07 |
| Marketing Category | NDA |
| Application Number | NDA204200 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-04-29 |
| Ingredient | Strength |
|---|---|
| EPINEPHRINE | 1 mg/mL |
| SPL SET ID: | 7663c49d-1b1d-755d-e053-2991aa0a4ee3 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |